Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy

Publisher： John Wiley & Sons Inc

E-ISSN： 1528-1167|56|6|915-923

ISSN： 0013-9580

Source： EPILEPSIA, Vol.56, Iss.6, 2015-06, pp. : 915-923

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Steady‐State Carbamazepine Pharmacokinetics Following Oral and Stable‐Labeled Intravenous Administration in Epilepsy Patients: Effects of Race and Sex

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 483-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous carbamazepine as short‐term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open‐label trials

By  

EPILEPSIA, Vol. 56, Iss. 6, 2015-06 ,pp. : 906-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generic lamotrigine versus brand‐name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard

By  

EPILEPSIA, Vol. 56, Iss. 9, 2015-09 ,pp. : 1415-1424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1149-1159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preferences of Patients with Advanced Colorectal Cancer for Treatment with Oral or Intravenous Chemotherapy

By Mastroianni Candida M.  

The Patient: Patient-Centered Outcomes Research, Vol. 1, Iss. 3, 2008-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite